A Phase 2 Study of Neoadjuvant Chemotherapy With Sequential Weekly Nanoparticle Albumin Bound Paclitaxel (Abraxane) Followed by 5-Fluorouracil, Epirubicin, Cyclophosphamide (FEC) in Locally Advanced Breast Cancer.
Phase of Trial: Phase II
Latest Information Update: 28 Oct 2014
At a glance
- Drugs Paclitaxel (Primary) ; Cyclophosphamide; Epirubicin; Fluorouracil
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 11 Aug 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 11 Aug 2008 Actual end date is now 1 Jul 2008 as reported by ClinicalTrials.gov.